ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed
Xiaoguang Chen
Matched on ORCID iD 0000-0001-6798-3687; OpenAlex author ID A5100649680. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 3
2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper
Papers 4
- Secreted HSP90α-LRP1 Signaling Promotes Tumor Metastasis and Chemoresistance in Pancreatic Cancer. Last author DOI 10.3390/ijms23105532↗
- Chaperone-mediated autophagy degradation of IGF-1Rβ induced by NVP-AUY922 in pancreatic cancer. Last author DOI 10.1007/s00018-019-03080-x↗
- LB-1 Exerts Antitumor Activity in Pancreatic Cancer by Inhibiting HIF-1α and Stat3 Signaling. Last author DOI 10.1002/jcp.24949↗
- Antiproliferative effect of HSP90 inhibitor Y306zh against pancreatic cancer is mediated by interruption of AKT and MAPK signaling pathways. Last author DOI 10.2174/1568009614666140908101523↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nina Xue · 3 shared papers, 2014–2022 · strength 0.33
- Paper Secreted HSP90α-LRP1 Signaling Promotes Tumor Metastasis and Chemoresistance in Pancreatic Cancer. DOI 10.3390/ijms23105532↗
- Paper Chaperone-mediated autophagy degradation of IGF-1Rβ induced by NVP-AUY922 in pancreatic cancer. DOI 10.1007/s00018-019-03080-x↗
- Paper Antiproliferative effect of HSP90 inhibitor Y306zh against pancreatic cancer is mediated by interruption of AKT and MAP… DOI 10.2174/1568009614666140908101523↗
- Jing Jin · 1 shared paper, 2019 · strength 0.09
- Fei Niu · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.